chronic kidney disease
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: CKD patients attending the study facilities
Exclusion criteria
Exclusion criteria: 1)End-stage kidney disease 2)Acute kidney injury 3)Type 1 diabetes or insulin-dependent dia betes 4)Diabetic ketoacidosis or hyperglycemic h yperosmolar syndrome 5)Liver failure 6)Malignancy 7)Active infectious disease 8)Surgery within 3 months prior to study enrollment (excluding minor surgery) 9)Other cases deemed inappropriate by the physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| decline in eGFR | — |
Secondary
| Measure | Time frame |
|---|---|
| Progression to end-stage kidney disease Progression to next stage of eGFR classification eGFR slope Cardiovascular disease event All-cause mortality Sarcopenia Falling and fructure | — |
Countries
Japan
Contacts
University of Yamanashi Hospital Department of Nephrology